Atacicept: Clinical Trials

3 trials of Atacicept, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated, 1 withdrawn. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 21Terminated 1

Follow Atacicept: new trials by email Literature Review of Atacicept trials Research Report on Atacicept

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Atacicept in Subjects With IgA Nephropathy
Atacicept, Placebo to match Atacicept - IgA Nephropathy, Berger Disease
Phase 3Active not recruitingVera Therapeutics, Inc.4282023-06-292026-10-01
Atacicept in Subjects With Active Lupus Nephritis (COMPASS)
Atacicept, Placebo - Lupus Nephritis (LN)
Phase 3WithdrawnVera Therapeutics, Inc.2022-11-022025-05-23
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
Atacicept, Mycophenolate mofetil, Placebo - Lupus Nephritis
Phase 2 / Phase 3TerminatedEMD Serono62007-12-012016-03-23

Conditions studied

Lupus Nephritis (2)  ·  Glomerulonephritis, IGA (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Nephritis (1)

Sponsors

Vera Therapeutics, Inc. (2)  ·  EMD Serono (1)

Countries

United States (3)  ·  Czechia (1)  ·  Malaysia (1)  ·  Puerto Rico (1)  ·  Singapore (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Eric Michael, MD (1)  ·  Joanne Curley (1)

Results publications

PMID 22325903, PMID 39462308, PMID 41196369, PMID 41620980